ENFN — Enfusion Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyAdventurousMid CapHigh Flyer

Annual balance sheet for Enfusion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	13.9	64.4	62.5	35.6	54.5
Net Total Accounts Receivable
Net Total Receivables	12.2	18.2	25.9	28.1	32
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.9	89.7	96.8	69.9	93.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.78	13.1	22.5	32.6	39
Long Term Notes Receivable
Other Long Term Assets
Total Assets	39.1	106	124	109	143
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.7	8.11	17.4	20.3	27.3
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	107	50.8	58.8	55.3	70
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-68	55.3	65	53.7	73.2
Total Liabilities & Shareholders' Equity	39.1	106	124	109	143
Total Common Shares Outstanding